Fuse Medical, Inc. financial data

Symbol
FZMD on OTC
Location
1565 North Central Expressway, Suite 220, Richardson, TX
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2023 - Aug 14, 2023

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 110 % -14.4%
Quick Ratio 79.5 % -12.5%
Debt-to-equity -1.65K % -177%
Return On Equity -321 % -737%
Return On Assets 20.7 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 73.9M shares +1.37%
Common Stock, Shares, Outstanding 73.9M shares +1.37%
Common Stock, Value, Issued 739K USD +1.37%
Weighted Average Number of Shares Outstanding, Basic 70.3M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 78M shares

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 18.4M USD -5.77%
Cost of Revenue 6.33M USD -19.6%
Operating Income (Loss) -122K USD +93.4%
Nonoperating Income (Expense) 3.9M USD +1597%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 3.77M USD
Income Tax Expense (Benefit) 26.5K USD +42.6%
Net Income (Loss) Attributable to Parent 3.98M USD
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 253K USD
Accounts Receivable, after Allowance for Credit Loss, Current 3.43M USD +15.8%
Inventory, Net 9.03M USD -3.53%
Assets, Current 12.8M USD -1.56%
Property, Plant and Equipment, Net 0 USD -100%
Intangible Assets, Net (Excluding Goodwill) 1.13M USD -10.4%
Goodwill 1.97M USD 0%
Assets 19.3M USD +1.39%
Accounts Payable, Current 4.24M USD -11.4%
Employee-related Liabilities, Current 107K USD
Accrued Liabilities, Current 5.61M USD +41.8%
Liabilities, Current 12.1M USD +6.52%
Liabilities 19.5M USD -14.7%
Retained Earnings (Accumulated Deficit) -2.44M USD +59.8%
Stockholders' Equity Attributable to Parent -232K USD +94.5%
Liabilities and Equity 19.3M USD +1.39%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 331K USD -33%
Net Cash Provided by (Used in) Financing Activities -268K USD +49%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 73.9M shares +1.37%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 63.1K USD
Interest Paid, Excluding Capitalized Interest, Operating Activities 28.4K USD +18.3%
Deferred Tax Assets, Valuation Allowance 2.44M USD +4.31%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 2.62M USD +2.69%
Depreciation 3.88K USD -44%
Property, Plant and Equipment, Gross 20.2K USD -95.4%
Deferred Tax Assets, Operating Loss Carryforwards 1.69M USD +17.7%
Preferred Stock, Shares Issued 0 shares
Deferred Federal Income Tax Expense (Benefit) 0 USD
Current Income Tax Expense (Benefit) 5.59K USD +15.2%
Preferred Stock, Shares Authorized 20M shares 0%
Unrecognized Tax Benefits 0 USD
Additional Paid in Capital 1.47M USD
Preferred Stock, Shares Outstanding 0 shares
Current State and Local Tax Expense (Benefit) 5.59K USD +15.2%
Current Federal Tax Expense (Benefit) 0 USD
Amortization of Intangible Assets 131K USD +34.5%
Depreciation, Depletion and Amortization 33.4K USD -2.84%
Deferred State and Local Income Tax Expense (Benefit) 0 USD
Interest Expense 213K USD +89.1%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%